![]() |
|
|
Vol. 30, Issue 1, 4-6, January 2002
Department of Hospital Pharmacy The expression levels of mRNAs for MDR1 (P-glycoprotein), multidrug
resistance-associated proteins (MRP1, MRP2), and cytochrome P450
3A (CYP3A) in Caco-2 cells were quantitatively compared with those in
human duodenal enterocytes, normal colorectal tissues, and colorectal
adenocarcinomas. Caco-2 cells (passages 36-88) were kindly supplied by
several laboratories in Japan. Human duodenal enterocytes were obtained
from five healthy male volunteers. Normal colorectal tissues and
colorectal adenocarcinomas were simultaneously obtained from seven
patients with primary colorectal adenocarcinoma. MDR1, MRP1, MRP2, and
CYP3A mRNA levels were determined by real-time quantitative polymerase
chain reactions (PCR). Relative concentrations of mRNAs for target
proteins (MDR1, MRP1, MRP2, and CYP3A) and glyceraldehyde-3-phosphate
dehydrogenase in Caco-2 cells were 1.00 ± 0.15, 1.02 ± 0.06, 0.94 ± 0.10, and 0.68 ±0.60, respectively, and those in
human enterocytes were about 12-, 3-, 7-, and 8000-fold higher than in
the Caco-2 cells, respectively. In contrast, MDR1, MRP1, and CYP3A mRNA
levels in Caco-2 cells were comparable to those in normal colorectal
tissue and colorectal adenocarcinoma.
(Ts.N, T.Sa., N.O., K.O.),
Second Department of Internal Medicine
(T.T., N.A., M.K),
First Department of Surgery
(T.K., Ta.N., Y.K.),
Department of
Urology (T.Sh.),
Departments of Clinical Genetics
and
International Center for
Medical Research (T.Sh., M.M.),
School of Medicine, Kobe University,
Kobe, Japan
Department of
Gastroenterology
(K.I.K., S.R.K.),
Kobe Asahi Hospital,
Kobe, Japan
This article has been cited by other articles:
![]() |
K. May, K. Westphal, T. Giessmann, D. Wegner, U. Adam, M. M. Lerch, R. Oertel, R. W. Warzok, W. Weitschies, M. Braeter, et al. Disposition and Antimuscarinic Effects of the Urinary Bladder Spasmolytics Propiverine: Influence of Dosage Forms and Circadian-Time Rhythms J. Clin. Pharmacol., May 1, 2008; 48(5): 570 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Lee, I-C. Ho, W.-J. Lu, and J.-d. Huang Enhanced Expression of Multidrug resistance-associated Protein 2 and Reduced Expression of Aquaglyceroporin 3 in an Arsenic-resistant Human Cell Line J. Biol. Chem., July 7, 2006; 281(27): 18401 - 18407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ludwig, G. Szakacs, S. E. Martin, B. F. Chu, C. Cardarelli, Z. E. Sauna, N. J. Caplen, H. M. Fales, S. V. Ambudkar, J. N. Weinstein, et al. Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in Cancer. Cancer Res., May 1, 2006; 66(9): 4808 - 4815. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, M. Imoto, H. Sakamoto, and M. Hashimoto IDENTIFICATION OF ESTERASES EXPRESSED IN CACO-2 CELLS AND EFFECTS OF THEIR HYDROLYZING ACTIVITY IN PREDICTING HUMAN INTESTINAL ABSORPTION Drug Metab. Dispos., August 1, 2005; 33(8): 1185 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zimmermann, H. Gutmann, P. Hruz, J.-P. Gutzwiller, C. Beglinger, and J. Drewe MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT Drug Metab. Dispos., February 1, 2005; 33(2): 219 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Michael and M.M. Doherty Tumoral Drug Metabolism: Overview and Its Implications for Cancer Therapy J. Clin. Oncol., January 1, 2005; 23(1): 205 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. von Moltke, B. W. Granda, J. M. Grassi, M. D. Perloff, D. Vishnuvardhan, and D. J. Greenblatt INTERACTION OF TRIAZOLAM AND KETOCONAZOLE IN P-GLYCOPROTEIN-DEFICIENT MICE Drug Metab. Dispos., August 1, 2004; 32(8): 800 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, X. Meng, C. Li, S. Sang, C. Patten, S. Sheng, J. Hong, N. Bai, B. Winnik, C.-T. Ho, et al. Glucuronides of Tea Catechins: Enzymology of Biosynthesis and Biological Activities Drug Metab. Dispos., April 1, 2003; 31(4): 452 - 461. [Abstract] [Full Text] [PDF] |
||||